Oliver Catlin

A commitment to sports anti-doping science and supplement research

Oliver Catlin, son of renowned anti-doping guru Don Catlin, M.D., has been working in the arena of sports anti-doping science and dietary supplement research and testing for nearly a decade. He is the CEO and President of BSCG.

Oliver started his career at the UCLA Olympic Analytical Laboratory as the director of finance and administration. In this position, he helped oversee the drug-testing programs for USADA and the U.S. Olympic Committee, the National Football League, Major League Baseball, the National Collegiate Association and the U.S. military and other organizations and sports leagues.

After leaving the UCLA Olympic Lab, Oliver continued working with Dr. Catlin and colleagues to found a number of organizations to address a range of issues related to sports anti-doping science, including identifying and developing tests for new and evolved banned substances, conducting drug testing in human and equine sports and working to buildhealthy sporting cultures for athletes.(The Catlin Consortium consists of the companies Anti-Doping Sciences Institute and BSCG as well as the nonprofit/NGO Anti-Doping Research and its public initiative Support Clean Sport.)

Building BSCG

At BSCG, Oliver has led the way in developing its Certified Drug Free brand, growing its sports testing menu andexecuting its testing on the prohibited list developed by the World Anti-Doping Agency, and expanding the company’s offerings by establishing the Equine & Canine Program and the Consumer Program. He is also intimately involved with BSCG work on a day-to-day basis, working closely with both responsible manufacturers and athletes to ensure their dietary supplements are free of banned and dangerous substances.

Contributing to the field

The primary contributor to The Catlin Perspective blog, Oliver is also active in helping the industry to navigate pressing and sometimes tricky issues. His highly regarded blog posts helped lead to Amazon.com’s banishing the sale ofdangerous dietary supplements, and have helped shed light on substances not often easily understood, including methylhexaneamine, clenbuterol and, most recently, deer-antler products.

An education in business

Oliver is a graduate of U.C. Berkeley’s Haas School of Business, where he studied financial analysis, enterprise resource planning and human resources/benefits/compensation.